Jan 9, 2017 ReWalk Robotics Announces 2017 Focus and Operating Initiatives
Dec 27, 2016 Thermography Inspection Company - DIR Technologies - Raises $10 Million
Dec 16, 2016 Recro Pharma Announces Closing of $40 Million Public Offering of Common Stock
Dec 14, 2016 Ivenix Announces Collaboration with Intelligraphics on Breakthrough Infusion Pump Platform
Nov 28, 2016 Recro Pharma Reports Positive Top-Line Results from Pivotal Phase III Clinical Trial of IV Meloxicam
Nov 21, 2016 Boston Area Startup Tackles ECRI's #1 Medical Technology Hazard
Nov 15, 2016 Endospan's Nexus Featured in EndoVascular Today Article, The Current State of Branched Stent Grafts for the Aortic Arch, Which Reviews Five FDA IDE-Approved Devices
Oct 27, 2016 ReWalk Robotics Prices Public Offering of Ordinary Shares and Warrants
Sep 26, 2016 Regentis Biomaterials Obtains FDA IDE Approval for its Pivotal GelrinC Clinical Trial
Sep 12, 2016 Two Studies Demonstrate Promising Results of Avedro's PiXL™ Procedure for Non-Invasive Treatment of Low Myopia
Sep 8, 2016 Avedro Strengthens its Executive Team with the Appointment of Dr. Reza Zadno as Chief Executive Officer
Sep 7, 2016 Recro Pharma Presents Clinical Data at PAINWeek 2016
Sep 7, 2016 ReWalk Robotics Achieves Milestone of 100 Personal Systems Sold
Aug 31, 2016 MST's AutoLap™ Named "Innovation of the Year"
Aug 19, 2016 Recro Pharma Announces Closing of Public Offering of Common Stock
Aug 15, 2016 Robotic Surgical Technology Expanding into Israeli Market
Aug 4, 2016 German Social Welfare Court Ruling Deems ReWalk Exoskeleton Medically Necessary as Medical Aid for Recipient with Spinal Cord Injury
Aug 2, 2016 ReWalk Robotics Launches a 522 Post-Market Study with Stanford University School of Medicine as Lead Investigator Site
Jul 26, 2016 Recro Pharma Reports Positive Top-Line Results from Pivotal Phase III Clinical Trial of IV Meloxicam
Jul 5, 2016 Recro Pharma Appoints Michael Celano as Chief Financial Officer
May 12, 2016 New Radar Technology by Sensible (ReDS) May Reduce Heart Failure Re-Hospitalization
May 9, 2016 ReWalk Announces Collaboration with Harvard University's Wyss Institute to Develop Lightweight and Soft Exoskeleton Systems
May 9, 2016 Commercial Health Insurance Company Becomes First to Implement Medical Policy Finding Powered Exoskeletons Medically Necessary
May 5, 2016 Department of Veterans Affairs Purchases 20 ReWalk Systems to Support National Multi-Center Trial Assessing Personal Exoskeleton System Use
May 4, 2016 Ivenix Appoints Susan Neimeier as Chief Nursing Officer
Apr 18, 2016 Avedro Receives FDA Approval for Photrexa Viscous, Photrexa and the KXL System for Corneal Cross-Linking
Mar 12, 2016 MST Launches Commercial Activities in the U.S. and Appoints Dennis Feldman as Senior Director of Sales & Marketing, USA
Feb 24, 2016 German Social and Youth Agency Reimburses ReWalk Robotics Exoskeleton for the First Time
Feb 7, 2016 Regentis Biomaterials Raises $15 Million. Financing Round Led by Chinese Pharmaceutical Group Haisco
Jan 27, 2016 Recro Pharma Initiates Pivotal Phase III Clinical Trial of IV Meloxicam for Acute Postoperative Pain
Jan 6, 2016 MST Obtains FDA Clearance for its "Follow Me™" Image-Guided Software
Jan 4, 2016 ReWalk Robotics Secures Line of Credit of Up to $20 Million to Support Market Building Activities
Dec 17, 2015 U.S. Department of Veterans Affairs Issues National Coverage Policy for ReWalk Robotics Exoskeleton Systems for Qualifying Veterans with Spinal Cord Injury
Nov 12, 2015 Avedro Completes New $32 Million Financing Round
Nov 3, 2015 China Food and Drug Administration (CFDA) Grants Approval for Avedro's KXL System
Nov 1, 2015 DIR Technologies Brings 100% Inspection and Quality Control to Heat Sealing with New DIR Eye
Oct 26, 2015 Recro Pharma Provides Pipeline Update
Oct 22, 2015 Chinese Pharmaceutical Company Haisco Pumps $10 Million into Israeli Heart Tech Company Endospan
Oct 19, 2015 Avedro Resubmits New Drug Application to FDA for Corneal Cross-Linking
Oct 10, 2015 Sensible Medical Innovations Enrolls First Patient in its SMILE Clinical Trial Designed to Measure ReDS Technology Impact on Heart Failure Rehospitalization
Sep 1, 2015 Ivenix Secures $42 Million in Funding
Jul 20, 2015 DIR Technologies Debuts the "Lite" Version of its Thermal Image-Driven Induction Seal Inspection Solution for Bottles
Jul 17, 2015 Recro Pharma Announces Positive Top-Line Results for Phase II Clinical Trial of Dex-IN
Jul 14, 2015 ReWalk Robotics Launches ReWalk 6.0: the Company's Sixth Generation Personal System for Home & Community Use
Jul 7, 2015 Recro Pharma Completes $16 Million Private Financing
Jun 30, 2015 MST Raises $12.5 Million Investment for Market Expansion
Jun 18, 2015 DIR Technologies Wins 2015 ACHEMA Innovation Award for Groundbreaking PAT Solutions for Pharmaceutical Packaging Applications
Apr 22, 2015 DIR Technologies Enters into Five-Year Collaboration Agreement with Pfizer
Feb 17, 2015 Ivenix Partners with the AAMI Foundation to Support the National Coalition for Infusion Therapy Safety
Feb 13, 2015 POCARED Diagnostics Raises $15 Million in Additional Funding
Jan 28, 2015 Garnet BioTherapeutics Files Amicus Brief to Support its Victory Against Athersys in Patent Interference
Jan 20, 2015 Avedro Appoints Brian Roberts as Chief Financial Officer
Dec 18, 2014 ReWalk Robotics Appoints Kevin Hershberger as Chief Financial Officer
Oct 29, 2014 Recro Pharma Announces Dosing of First Patient in Phase II REC-14-013 Clinical Trial of Dex-IN for Treatment of Acute Pain on Day 1 Following Surgery
Sep 23, 2014 ReWalk Robotics Announces Reimbursement Coverage by Major German Insurance Company
Sep 12, 2014 ReWalk Robotics Announces Pricing of Initial Public Offering
Sep 4, 2014 Recro Pharma Provides Clinical Strategy Update Following Interim Analysis for Phase IIb Clinical Trial of Dex-IN
Sep 3, 2014 Avedro Acquires Assets of IROC Innocross AG, Including its UV-X Line of Cross-Linking Devices
Jul 10, 2014 ReWalk Robotics Files Registration Statement for Initial Public Offering
Jun 26, 2014 Ivenix Designs Next-Generation Infusion Management System to Transform the Infusion Pump Market
Jun 26, 2014 ReWalk™ Personal Exoskeleton System Cleared by FDA for Home Use
Jun 17, 2014 Recro Pharma Announces Dosing of its First Patient in Phase IIb Clinical Trial of Dex-IN
May 20, 2014 Sensible Medical Innovation Obtains CE Mark
May 8, 2014 ReWalk Named 2014 New England Innovation of the Year
Mar 25, 2014 DIR Technologies Adds Two Pharmaceutical Industry Veterans to its Executive Advisory Board
Mar 12, 2014 Recro Pharma Announces Closing of its Initial Public Offering
Feb 25, 2014 Avedro Announces the Start of Two New US FDA Trials for Accelerated Cross-Linking
Nov 11, 2013 Sensible Medical Innovations Closes Financing Round Led by Boston Scientific
Nov 5, 2013 Avedro Announces CE Mark for its KXL II Advanced Cross-Linking System
Oct 1, 2013 MST Obtains FDA Clearance for New Laparoscopic Positioner for Minimally Invasive Surgeries
Sep 25, 2013 ARGO Medical Technologies Announces Investment and Strategic Partnership with YASKAWA Electric Company
Sep 20, 2013 MST, A Leader in Video Analytics & Robotics for Minimally Invasive Surgeries, Closes a Series B Financing Round
Sep 16, 2013 Hydrogel Implant GelrinC Demonstrates Impressive Recovery Rates for Patients with Knee Cartilage Damage
Aug 6, 2013 POCARED Diagnostics Appoints Former Becton Dickinson CEO, Mr. Edward J. Ludwig, to its Board of Directors
May 1, 2013 Wide Impact of novoGI Nitinol Compression Anastomosis at the 2013 Annual ASCRS Meeting
Apr 10, 2013 Regentis Biomaterials Expands Clinical Study of GelrinC for Cartilage Repair
Mar 18, 2013 Regentis Biomaterials Receives European CE Mark Approval for GelrinC
Mar 5, 2013 Avedro Completes $43 Million Series D Financing Round
Jan 22, 2013 ARGO Medical Technologies Unveils Advancement of its Exoskeleton Technology with Launch of ReWalk Rehabilitation 2.0
Jan 10, 2013 The American Journal of Surgery Publishes Analysis Corroborating Successful Outcomes for novoGI Compression Anastomosis
Dec 31, 2012 novoGI Acquires an Exclusive License to Brand and Market a Next-Generation GI Endoscopic Video Processing Standalone Solution
Oct 11, 2012 ARGO Medical Technologies Announces European Commercial Launch of the ReWalk Exoskeleton for Personal Use
Oct 11, 2012 Keraflex® Keratoconus Treatment Study Begins in the U.S.
Sep 4, 2012 New Era Starts as ReWalk Exoskeleton Technology is Avaliable to Take Home
Aug 24, 2012 Claire Lomas Lights the Paralympics Ceremonial Cauldron
Aug 15, 2012 novoGI Announces Licensing Agreement with Unique Surgical Innovations
Jun 12, 2012 Avedro Announces CE Mark for its Newest Riboflavin Formulations
Jun 4, 2012 novoGI Announces New Studies on Compression Anastomosis Presented at the Annual Meeting of the American Society of Colorectal Surgeons 2012
Jun 1, 2012 NiTi Surgical Solutions Renamed novoGI, Focuses on Providing Novel Solutions for GI Disease Management
May 14, 2012 Regentis Biomaterials Announces $10m Raised in Series C Financing Round
May 8, 2012 With Help of a 'Bionic' Suit, Paralyzed Woman Finishes London Marathon
Apr 3, 2012 ACOS and Avedro Announce Initiation of a Phase III Study on Accelerated Corneal Cross-Linking
Jan 4, 2012 Avedro Announces CE Approval for Lasik Xtra™
Sep 12, 2011 Avedro Announces FDA Orphan Drug Designation for its Corneal Cross-Linking System for Treatment of Keratoconus
Aug 19, 2011 MossRehab Makes Strides with Robotic Walking Devices
Aug 16, 2011 FluidNet Completes $25 Million Series C Financing Round
Jul 25, 2011 MossRehab First in the U.S. to Offer Therapeutic Use of ReWalk™ Device
Jul 7, 2011 Avedro Completes $25 Million Series C Financing Round
Apr 6, 2011 Aro Medical's Revolutionary Exoskeleton, ReWalk, To Go On Sale in the UK
Jan 26, 2011 The Right Trousers: Argo's Exoskeleton Brings Hope and Dignity to Paraplegics
Dec 3, 2010 Recro Pharma in Philadelphia Business Journal
Oct 21, 2010 Reborn: Opportunity Abounds in Biosciences
Dec 7, 2009 Regentis Biomaterials Announces First Patient Treated in its Cartilage Clinical Study
Sep 2, 2009 SemiConductor Devices and SCP Vitalife Launch Infrared Technology Company - DIR Technologies
Jun 24, 2009 Sensible Medical Innovations Raises $7 Million in its Series A Financing Round
May 14, 2009 COPAN and Pocared Disgnostics Partner on Next Generation Microbiology Systems
Feb 3, 2009 Regenerative Medicine Company Garnet Biotherapeutics Raises $10.4 Million
Aug 21, 2007 Regentis Biomaterials Completes $7.5 Million Series B Financing Round
Jun 12, 2007 Pocared Diagnostics Raises $10.7 Million in Series D Financing Round